Conjunctivitis
Showing 1 - 25 of 3,638
Allergic Conjunctivitis Trial in Andover (TL-925, Placebo)
Recruiting
- Allergic Conjunctivitis
- TL-925
- Placebo
-
Andover, MassachusettsAndover Eye Associates
Nov 29, 2023
Allergic Conjunctivitis Trial in Taichung (Vitamin D, Placebo)
Recruiting
- Allergic Conjunctivitis
- Vitamin D
- Placebo
-
Taichung, TaiwanChina Medical University Hospital
May 1, 2023
Allergic Conjunctivitis Trial in Adelaide (MDI-1228_mesylate Ophthalmic Solution, Placebo)
Recruiting
- Allergic Conjunctivitis
- MDI-1228_mesylate Ophthalmic Solution
- Placebo
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Jul 24, 2023
Acute Bacterial Conjunctivitis Trial (IVIEW-1201, Ofloxacin Eye Drops)
Not yet recruiting
- Acute Bacterial Conjunctivitis
- IVIEW-1201
- Ofloxacin Eye Drops
- (no location specified)
Apr 13, 2023
Ligneous Conjunctivitis Trial in Indianapolis, Florence, Padova (Human Plasminogen)
Completed
- Ligneous Conjunctivitis
- Human Plasminogen
-
Indianapolis, Indiana
- +2 more
Jan 2, 2023
Allergic Conjunctivitis, Dry Eye, Dry Eye Disease Trial in Catanzaro (HPMC-HA eyedrops)
Completed
- Allergic Conjunctivitis
- +2 more
- HPMC-HA eyedrops
-
Catanzaro, CZ, ItalyAzienda Ospedaliera Policlinico Mater Domini - Università Magna
Apr 13, 2023
Allergic Conjunctivitis Trial in Phoenix, Andover, Memphis (Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo,
Not yet recruiting
- Allergic Conjunctivitis
- Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo
- +3 more
-
Phoenix, Arizona
- +2 more
Nov 9, 2022
Conjunctivitis, Allergic Trial in United States (ADX-102 Ophthalmic Drops (0.5%), ADX-102 Ophthalmic Drops (0.1%), Vehicle of
Completed
- Conjunctivitis, Allergic
- ADX-102 Ophthalmic Drops (0.5%)
- +2 more
-
Morrow, Georgia
- +4 more
Dec 14, 2022
Seasonal Allergic Conjunctivitis Trial in Andover, Memphis (Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic
Not yet recruiting
- Seasonal Allergic Conjunctivitis
- Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic Solution
- +3 more
-
Andover, Massachusetts
- +1 more
Nov 9, 2022
Allergic Conjunctivitis Trial in Andover (PRT-2761 0.5%, PRT-2761 1%, Patanol)
Completed
- Allergic Conjunctivitis
- PRT-2761 0.5%
- +4 more
-
Andover, MassachusettsAndover Eye Associates
Oct 13, 2022
Allergic Conjunctivitis, Dry Eye, Dry Eye Disease Trial in Catanzaro (Eye drops for itchy and water eyes)
Completed
- Allergic Conjunctivitis
- +2 more
- Eye drops for itchy and water eyes
-
Catanzaro, CZ, ItalyAzienda Ospedaliera Policlinico Mater Domini - Università Magna
Apr 11, 2023
Food-specific IgG4-guided Elimination Diets Improve Allergy
Completed
- Rhinitis, Allergic
- +4 more
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital,School of Medicine,Zhejiang Universit
Sep 25, 2023
Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035%
Not yet recruiting
- Allergic Conjunctivitis
- rimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution (Combo)
- Vehicle of brimonidine tartrate 0.025%/ketotifen fumarate 0.035% ophthalmic solution
- (no location specified)
Apr 4, 2023
Plasminogen Deficiency Trial in Saskatoon (Aliquoted allogeneic donor plasma in patient's conjunctiva)
Not yet recruiting
- Plasminogen Deficiency
- Aliquoted allogeneic donor plasma in patient's conjunctiva
-
Saskatoon, Saskatchewan, CanadaUniversity of Saskatchewan
Nov 7, 2022
Allergic Conjunctivitis, Allergic Rhinitis Trial in Vienna (Eye Drops, Solution in Single-Dose Container)
Completed
- Allergic Conjunctivitis
- Allergic Rhinitis
- Eye Drops, Solution in Single-Dose Container
-
Vienna, AustriaVienna Challenge Chamber
Aug 24, 2022
Allergic Conjunctivitis Trial in Andover (VSJ-110, Placebo)
Completed
- Allergic Conjunctivitis
- VSJ-110
- Placebo
-
Andover, MassachusettsVanda Investigational Site
Apr 26, 2022
Bilateral Conjunctivitis (Disorder) Trial in Pompano Beach (Dexamethasone ophthalmic insert 0.4Mg, 0.2% loteprednol etabonate
Completed
- Bilateral Conjunctivitis (Disorder)
- Dexamethasone ophthalmic insert 0.4Mg
- +2 more
-
Pompano Beach, FloridaClinical Research Center of Florida
Apr 6, 2022
Acute Infectious Conjunctivitis (Disorder) Trial in Jackson Heights (SCH-1, Placebo)
Recruiting
- Acute Infectious Conjunctivitis (Disorder)
- SCH-1
- Placebo
-
Jackson Heights, New YorkJacqueline Dauhajre, MD
Apr 26, 2022
Allergic Conjunctivitis Trial in Andover (olopatadine HCl ophthalmic solution 0.7%), Fluticasone Propionate, Tears Naturale)
Recruiting
- Allergic Conjunctivitis
- olopatadine hydrochloride ophthalmic solution 0.7%)
- +3 more
-
Andover, MassachusettsAndover Eye Associates
Jul 18, 2022
Allergic Conjunctivitis Trial in Mississauga (Reproxalap Ophthalmic Solution (0.25%), Vehicle Ophthalmic Solution)
Recruiting
- Allergic Conjunctivitis
- Reproxalap Ophthalmic Solution (0.25%)
- Vehicle Ophthalmic Solution
-
Mississauga, Ontario, CanadaCliantha Research
May 5, 2022
Viral Conjunctivitis Trial in Miami (0.01% Hypochlorous acid, Placebo)
Terminated
- Viral Conjunctivitis
- 0.01% Hypochlorous acid
- Placebo
-
Miami, FloridaUniversity of Miami Bascom Palmer Eye Institute
Nov 29, 2021
Malnutrition, Diabetes, Inflammation Trial in Karachi (Fermented High Zinc Wheat Flour Flatbread, Unfermented High Zinc Wheat
Recruiting
- Malnutrition
- +3 more
- Fermented High Zinc Wheat Flour Flatbread
- +3 more
-
Karachi, Sindh, PakistanAga Khan University
Oct 18, 2023
Ligneous Conjunctivitis, Left Eye Trial in St. John's (Allogenic plasma aliquots, a source of plasminogen)
Enrolling by invitation
- Ligneous Conjunctivitis, Left Eye
- Allogenic plasma aliquots, a source of plasminogen
-
St. John's, Newfoundland and Labrador, CanadaMemorial University of Newfoundland
Apr 5, 2022
Allergic Rhinitis, Conjunctivitis Trial (REGN5713, REGN5714, REGN5715)
Not yet recruiting
- Allergic Rhinitis
- Conjunctivitis
- REGN5713
- +3 more
- (no location specified)
Jun 20, 2022